MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS, RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS, RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Living Drug' to reset immune system in MS patients
Disease control Not yet recruitingThis early-stage study is testing a new personalized therapy called CABA-201 for adults with multiple sclerosis (MS) that hasn't responded well to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target the cells thought to drive MS, an…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Can walking more improve your sex life? new study for women with MS
Symptom relief Not yet recruitingThis study is testing if a 16-week online exercise program can help improve sexual function for women with multiple sclerosis (MS). Researchers will enroll 30 women with MS who report sexual difficulties and who are not currently very active. The goal is to see if increasing phys…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
AI hunts for hidden clues in MS Patients' data
Knowledge-focused Not yet recruitingThis study aims to better understand Multiple Sclerosis (MS) by collecting and analyzing health data from about 100 patients over five years. Researchers will use artificial intelligence to look for patterns in medical records, scans, and blood tests that might predict how the di…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Sponsor: Luxembourg Institute of Health • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC